⁍ Swiss drugmaker Novartis said third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago.
⁍ Analysts polled by Refinitiv had, on average, forecast $3.2 billion.
⁍ For 2020, the Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth.
– Swiss drugmaker Novartis said on Tuesday that third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago. Analysts polled by Refinitiv had, on average, forecast $3.2 billion. For 2020, the Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.
Source: https://www.reuters.com/article/novartis-results/novartis-third-quarter-core-net-income-rises-to-347-billion-idUSKBN27C0M2